Join this one-of-a-kind forum designed exclusively for leaders and innovators in Treg-directed therapies. Dive into intricate Treg biology with expert scientists as they unravel Treg pathways, mechanisms of action, and explore their unique roles in the brain. Connect with industry pioneers and executives from both Treg cell therapy and modulator companies driving advancements in treatments for autoimmune and inflammatory indications.

This summit uncovers cutting-edge preclinical and clinical research, aiming to streamline and accelerate the journey of autologous and allogenic cell therapies and TNFR2 and nanomedicine-based modulators, from early concept to clinical application.